Why Gout Attacks the Foot First

Gout is a form of inflammatory arthritis caused by deposition of monosodium urate (MSU) crystals in joints and soft tissues. The condition results from hyperuricemia—elevated uric acid levels in the blood—that cause urate crystals to precipitate out of solution and accumulate in joints. The first metatarsophalangeal (MTP) joint of the big toe is the most common initial site, affected in approximately 50% of first attacks and 90% of patients with recurrent gout. This phenomenon is called podagra.

Several factors explain why the foot is the predilection site. Temperature is critical: urate crystals are more likely to precipitate at cooler temperatures, and the feet—being the most distal extremity—are the coolest part of the body. The big toe MTP joint bears tremendous mechanical load (up to 3× body weight during gait), which may contribute to crystal deposition. Joints of the ankle, midfoot, and knee are also commonly affected, particularly with recurrent disease.

Recognizing a Gout Attack

An acute gout attack is one of the most dramatic presentations in podiatry. The joint typically becomes intensely painful within hours—often beginning at night and waking patients from sleep. The affected joint (usually the big toe MTP) becomes swollen, warm, red, and exquisitely tender. The pain is often described as the worst pain the patient has ever experienced. Even light touch—from bed sheets, socks, or air movement—can be unbearable.

The attack typically peaks within 24–36 hours and resolves spontaneously over 7–10 days even without treatment. The skin may peel as the acute phase resolves. Between attacks (intercritical gout), most patients are completely asymptomatic. However, untreated gout leads to increasingly frequent and prolonged attacks, eventually resulting in chronic tophaceous gout—accumulation of urate deposits (tophi) in soft tissues and chronic joint destruction.

Common Gout Triggers

Understanding triggers allows patients to reduce attack frequency. Dietary purines (which metabolize to uric acid) are the classic trigger: organ meats, shellfish, red meat, and game meats are highest in purines. Alcohol—particularly beer and spirits—increases uric acid production and decreases renal excretion. Fructose-containing beverages (fruit juices, sodas) also increase uric acid production. Dehydration concentrates uric acid and is a frequent precipitant. Sudden illness, surgery, hospitalization, diuretic medications (hydrochlorothiazide, furosemide), low-dose aspirin, and rapid changes in uric acid levels (from starting urate-lowering therapy) can all trigger acute attacks.

Diagnosing Gout

The definitive diagnosis of gout requires joint aspiration with identification of needle-shaped, negatively birefringent monosodium urate crystals under polarized light microscopy. However, clinical diagnosis is highly accurate in classic presentations (sudden-onset podagra in a middle-aged man with hyperuricemia). Serum uric acid levels are helpful but imperfect—levels can be normal during an acute attack as urate shifts into inflamed tissue. X-rays in early gout are normal; chronic gout shows the classic “rat bite” erosions with overhanging edges and preserved joint space.

Dual-energy CT scanning (DECT) can detect urate crystal deposition before it is visible on conventional X-ray and is increasingly used for diagnostic confirmation. Ultrasound can demonstrate the “double contour sign”—a white hyperechoic layer over the articular cartilage caused by crystal deposition—that is highly specific for gout.

Treating an Acute Gout Attack

NSAIDs

Nonsteroidal anti-inflammatory drugs (NSAIDs) are first-line treatment for acute gout attacks in patients without contraindications. Indomethacin and naproxen are most commonly used. Treatment should begin at the onset of symptoms—early initiation significantly shortens attack duration. Full anti-inflammatory doses are used (not the lower doses used for pain relief). NSAIDs are contraindicated in patients with renal insufficiency, peptic ulcer disease, heart failure, and those on anticoagulants.

Colchicine

Colchicine inhibits neutrophil migration into the joint, directly interrupting the inflammatory cascade of acute gout. Low-dose colchicine (1.2mg at onset, then 0.6mg one hour later) is as effective as high-dose with substantially fewer gastrointestinal side effects. Colchicine is most effective when started within the first 24–36 hours of an attack—the earlier, the better. It is also used for long-term prophylaxis at 0.6mg daily in patients starting urate-lowering therapy.

Corticosteroids

Intra-articular cortisone injection provides rapid, targeted relief for gout attacks in a specific joint and is particularly appropriate when NSAIDs and colchicine are contraindicated (renal disease, GI bleeding, drug interactions). A single injection into the affected joint typically resolves the acute attack within 24–48 hours. Oral or intramuscular steroids are an alternative when multiple joints are involved or injection isn’t feasible.

Long-Term Gout Management and Prevention

Treating acute attacks is only part of gout management. Long-term urate-lowering therapy (ULT) is indicated for patients with two or more attacks per year, tophi, chronic gouty arthritis, or gout with renal complications. The target serum uric acid level for most patients is below 6 mg/dL (below 5 mg/dL for patients with tophi).

Allopurinol is the most commonly used ULT—it inhibits xanthine oxidase, the enzyme that converts purines to uric acid. Febuxostat is an alternative for patients who cannot tolerate allopurinol. When starting ULT, the rapid change in uric acid levels can paradoxically trigger acute attacks—prophylactic colchicine or NSAID is typically added for the first 3–6 months of ULT.

Dietary modifications have a meaningful but limited impact on uric acid levels (diet can reduce serum urate by about 1 mg/dL). Avoiding high-purine foods, alcohol (especially beer), and fructose-containing beverages, staying well-hydrated, and achieving a healthy weight are all appropriate lifestyle recommendations, but most patients with gout will require medication to achieve target uric acid levels.

Frequently Asked Questions

Medical References & Sources

• Arthritis Foundation — Gout
• American College of Rheumatology — Gout Treatment Guidelines
• PubMed Research — Gout Treatment

Dr. Tom Biernacki, DPM is a board-certified podiatric surgeon at Balance Foot & Ankle in Howell and Bloomfield Hills, Michigan. He diagnoses and treats acute gout attacks and works with patients on long-term gout management in coordination with primary care and rheumatology.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.